{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T12:49:34Z","timestamp":1779281374700,"version":"3.51.4"},"reference-count":35,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,11]],"date-time":"2023-01-11T00:00:00Z","timestamp":1673395200000},"content-version":"vor","delay-in-days":559,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["mp.uscap.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Modern Pathology"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1038\/s41379-021-00739-4","type":"journal-article","created":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T03:04:32Z","timestamp":1612148672000},"page":"1358-1366","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["Clinical, immunophenotypic and genomic findings of NK lymphoblastic leukemia: a study from the Bone Marrow Pathology Group"],"prefix":"10.1016","volume":"34","author":[{"given":"Olga K.","family":"Weinberg","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1898-1252","authenticated-orcid":false,"given":"Karen M.","family":"Chisholm","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6822-7880","authenticated-orcid":false,"given":"Chi Young","family":"Ok","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2135-2908","authenticated-orcid":false,"given":"Yuri","family":"Fedoriw","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bartosz","family":"Grzywacz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jason H.","family":"Kurzer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emily F.","family":"Mason","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2258-4444","authenticated-orcid":false,"given":"Karen A.","family":"Moser","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Siddharth","family":"Bhattacharya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mina","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"Babu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kathryn","family":"Foucar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4283-0005","authenticated-orcid":false,"given":"Wayne","family":"Tam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adam","family":"Bagg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Attilio","family":"Orazi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5478-7847","authenticated-orcid":false,"given":"Tracy I.","family":"George","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sa A.","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2160-9689","authenticated-orcid":false,"given":"Daniel A.","family":"Arber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert P.","family":"Hasserjian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1038\/s41379-021-00739-4_bib1","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1182\/blood-2008-02-135871","article-title":"Human natural killer cells exposed to IL-2, IL-12, IL-18, or IL-4 differently modulate priming of naive T cells by monocyte-derived dendritic cells","volume":"112","author":"Agaugu\u00e9","year":"2008","journal-title":"Blood."},{"key":"10.1038\/s41379-021-00739-4_bib2","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1182\/blood-2004-10-4035","article-title":"NK-dependent DC maturation is mediated by TNFalpha and IFNgamma released upon engagement of the NKp30 triggering receptor","volume":"106","author":"Vitale","year":"2005","journal-title":"Blood."},{"key":"10.1038\/s41379-021-00739-4_bib3","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.coi.2005.03.004","article-title":"The dialogue between human natural killer cells and dendritic cells","volume":"17","author":"Moretta","year":"2005","journal-title":"Curr Opin Immunol."},{"key":"10.1038\/s41379-021-00739-4_bib4","doi-asserted-by":"crossref","first-page":"2818","DOI":"10.4049\/jimmunol.1500325","article-title":"Priming of human resting NK cells by autologous M1 macrophages via the engagement of IL-1\u03b2, IFN-\u03b2, and IL-15 pathways","volume":"195","author":"Mattiola","year":"2015","journal-title":"J Immunol."},{"issue":"Mar","key":"10.1038\/s41379-021-00739-4_bib5","doi-asserted-by":"crossref","first-page":"3548","DOI":"10.1182\/blood-2010-04-281394","article-title":"Natural killer-cell differentiation by myeloid progenitors","volume":"117","author":"Grzywacz","year":"2011","journal-title":"Blood"},{"key":"10.1038\/s41379-021-00739-4_bib6","doi-asserted-by":"crossref","first-page":"5449","DOI":"10.1182\/blood-2010-11-318956","article-title":"Identification of the earliest NK-cell precursor in the mouse BM","volume":"117","author":"Carotta","year":"2011","journal-title":"Blood."},{"key":"10.1038\/s41379-021-00739-4_bib7","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.immuni.2015.07.011","article-title":"Identification of a human natural killer cell lineage-restricted progenitor in fetal and adult tissues","volume":"43","author":"Renoux","year":"2015","journal-title":"Immunity"},{"key":"10.1038\/s41379-021-00739-4_bib8","doi-asserted-by":"crossref","first-page":"3824","DOI":"10.1182\/blood-2006-04-020198","article-title":"Coordinated acquisition of inhibitory and activating receptors and functional properties by developing human natural killer cells","volume":"108","author":"Grzywacz","year":"2006","journal-title":"Blood"},{"key":"10.1038\/s41379-021-00739-4_bib9","unstructured":"Swerdlow SH, Campo E, Harris NL, et al., eds. WHO classification of tumors of haematopoietic and lymphoid tissues. Revised 4th edition ed. Lyon: IARC; 2017."},{"key":"10.1038\/s41379-021-00739-4_bib10","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1002\/cncr.21268","article-title":"Blastic natural killer cell lymphoma\/leukemia (CD56-positive blastic tumor): prognostication and categorization according to anatomic sites of involvement","volume":"104","author":"Suzuki","year":"2005","journal-title":"Cancer."},{"key":"10.1038\/s41379-021-00739-4_bib11","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1309\/UUXV-YRL8-GXP7-HR4H","article-title":"Blastic natural killer cell lymphoma\/leukemia: a report of seven cases","volume":"117","author":"Bayerl","year":"2002","journal-title":"Am J Clin Pathol."},{"key":"10.1038\/s41379-021-00739-4_bib12","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1080\/10428190290017088","article-title":"Pediatric acute blastic natural killer cell leukemia","volume":"43","author":"DuBois","year":"2002","journal-title":"Leuk Lymphoma."},{"key":"10.1038\/s41379-021-00739-4_bib13","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1182\/blood-2015-08-661702","article-title":"Early T-cell precursor acute lymphoblastic leukemia\/lymphoma (ETP-ALL\/LBL) in adolescents and adults: a high-risk subtype","volume":"127","author":"Jain","year":"2016","journal-title":"Blood."},{"key":"10.1038\/s41379-021-00739-4_bib14","doi-asserted-by":"crossref","first-page":"224","DOI":"10.3324\/haematol.13543","article-title":"CD56 expression in T-cell acute lymphoblastic leukemia is associated with non-thymic phenotype and resistance to induction therapy but no inferior survival after risk-adapted therapy","volume":"94","author":"Fischer","year":"2009","journal-title":"Haematologica."},{"key":"10.1038\/s41379-021-00739-4_bib15","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1111\/j.1365-2141.2008.07457.x","article-title":"The presence of CD56\/CD16 in T-cell acute lymphoblastic leukaemia correlates with the expression of cytotoxic molecules and is associated with worse response to treatment","volume":"144","author":"Dalmazzo","year":"2009","journal-title":"Br J Haematol."},{"key":"10.1038\/s41379-021-00739-4_bib16","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1111\/bjh.15503","article-title":"Expression of CD56 defines a distinct subgroup in childhood T-ALL with inferior outcome. Results of the ALL-BFM 2000 trial","volume":"183","author":"Fuhrmann","year":"2018","journal-title":"Br J Haematol."},{"key":"10.1038\/s41379-021-00739-4_bib17","doi-asserted-by":"crossref","first-page":"202","DOI":"10.5581\/1516-8484.20110054","article-title":"The expression of CD56 antigen is associated with poor prognosis in patients with acute myeloid leukemia","volume":"33","author":"Alegretti","year":"2011","journal-title":"Rev Bras Hematol Hemoter."},{"key":"10.1038\/s41379-021-00739-4_bib18","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1200\/JCO.2000.18.6.1295","article-title":"CD56 expression is an indicator of poor clinical outcome in patients with acute promyelocytic leukemia treated with simultaneous all-trans-retinoic acid and chemotherapy","volume":"18","author":"Ferrara","year":"2000","journal-title":"J Clin Oncol."},{"key":"10.1038\/s41379-021-00739-4_bib19","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1016\/j.leukres.2004.01.006","article-title":"Extramedullary infiltrates of AML are associated with CD56 expression, 11q23 abnormalities and inferior clinical outcome","volume":"28","author":"Chang","year":"2004","journal-title":"Leuk Res."},{"key":"10.1038\/s41379-021-00739-4_bib20","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1002\/hon.2516","article-title":"Adverse outcome of AML with aberrant CD16 and CD56 NK cell marker expression","volume":"36","author":"Junge","year":"2018","journal-title":"Hematol Oncol."},{"key":"10.1038\/s41379-021-00739-4_bib21","doi-asserted-by":"crossref","first-page":"2417","DOI":"10.1182\/blood.V90.6.2417","article-title":"CD7+ and CD56+ myeloid\/natural killer cell precursor acute leukemia: a distinct hematolymphoid disease entity","volume":"90","author":"Suzuki","year":"1997","journal-title":"Blood."},{"key":"10.1038\/s41379-021-00739-4_bib22","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1182\/blood.V84.1.244.244","article-title":"HLA-DR-, CD33+, CD56+, CD16- myeloid\/natural killer cell acute leukemia: a previously unrecognized form of acute leukemia potentially misdiagnosed as French-American-British acute myeloid leukemia-M3","volume":"84","author":"Scott","year":"1994","journal-title":"Blood."},{"key":"10.1038\/s41379-021-00739-4_bib23","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1038\/s41379-019-0263-3","article-title":"Clinical, immunophenotypic, and genomic findings of acute undifferentiated leukemia and comparison to acute myeloid leukemia with minimal differentiation: a study from the bone marrow pathology group","volume":"32","author":"Weinberg","year":"2019","journal-title":"Mod Pathol."},{"key":"10.1038\/s41379-021-00739-4_bib24","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1200\/JCO.1990.8.5.813","article-title":"Report of the National Cancer Institute-sponsored workshop on definitions of diagnosis and response in acute myeloid leukemia","volume":"8","author":"Cheson","year":"1990","journal-title":"J Clin Oncol."},{"key":"10.1038\/s41379-021-00739-4_bib25","doi-asserted-by":"crossref","first-page":"892","DOI":"10.3389\/fimmu.2017.00892","article-title":"CD56 in the immune system: more than a marker for cytotoxicity?","volume":"8","author":"Van Acker","year":"2017","journal-title":"Front Immunol."},{"key":"10.1038\/s41379-021-00739-4_bib26","doi-asserted-by":"crossref","first-page":"2040","DOI":"10.1177\/2040620719874733","article-title":"Recent developments in the treatment of blastic plasmacytoid dendritic cell neoplasm","volume":"10","author":"Economides","year":"2019","journal-title":"Ther Adv Hematol."},{"key":"10.1038\/s41379-021-00739-4_bib27","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1182\/blood-2010-04-277434","article-title":"Clinical significance of CD56 expression in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and anthracycline-based regimens","volume":"117","author":"Montesinos","year":"2011","journal-title":"Blood."},{"key":"10.1038\/s41379-021-00739-4_bib28","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1111\/j.1600-0609.2005.00607.x","article-title":"Correlation between expression of CD56\/NCAM and severe leukostasis in hyperleukocytic acute myelomonocytic leukaemia","volume":"76","author":"Novotny","year":"2006","journal-title":"Eur J Haematol."},{"key":"10.1038\/s41379-021-00739-4_bib29","first-page":"ELT26","article-title":"CD56 in T-cell acute lymphoblastic leukaemia: a malignant transformation of an early myeloid-lymphoid progenitor","volume":"88","author":"Montero","year":"2003","journal-title":"Haematologica."},{"key":"10.1038\/s41379-021-00739-4_bib30","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1532\/IJH97.04061","article-title":"Two entities of precursor T-cell lymphoblastic leukemia\/lymphoma based on radiologic and immunophenotypic findings","volume":"80","author":"Onishi","year":"2004","journal-title":"Int J Hematol."},{"key":"10.1038\/s41379-021-00739-4_bib31","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1002\/1096-8652(200103)66:3<189::AID-AJH1043>3.0.CO;2-A","article-title":"Rare adult acute lymphocytic leukemia with CD56 expression in the ECOG experience shows unexpected phenotypic and genotypic heterogeneity","volume":"66","author":"Paietta","year":"2001","journal-title":"Am J Hematol"},{"key":"10.1038\/s41379-021-00739-4_bib32","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/S0145-2126(01)00188-6","article-title":"CD56 expression predicts occurrence of CNS disease in acute lymphoblastic leukemia","volume":"26","author":"Ravandi","year":"2002","journal-title":"Leuk Res."},{"key":"10.1038\/s41379-021-00739-4_bib33","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1111\/j.1365-2141.2011.08955.x","article-title":"Clinical significance of early T-cell precursor acute lymphoblastic leukaemia: results of the Tokyo Children's Cancer Study Group Study L99-15","volume":"156","author":"Inukai","year":"2012","journal-title":"Br J Haematol."},{"key":"10.1038\/s41379-021-00739-4_bib34","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1007\/s11684-012-0224-4","article-title":"Early T-cell precursor leukemia: a subtype of high risk childhood acute lymphoblastic leukemia","volume":"6","author":"Ma","year":"2012","journal-title":"Front Med."},{"key":"10.1038\/s41379-021-00739-4_bib35","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1111\/j.1600-065X.2006.00451.x","article-title":"Human natural killer cell development","volume":"214","author":"Freud","year":"2006","journal-title":"Immunol Rev."}],"container-title":["Modern Pathology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41379-021-00739-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41379-021-00739-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0893395222005865?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0893395222005865?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41379-021-00739-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T00:36:31Z","timestamp":1760229391000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0893395222005865"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7]]},"references-count":35,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2021,7]]}},"alternative-id":["S0893395222005865"],"URL":"https:\/\/doi.org\/10.1038\/s41379-021-00739-4","relation":{},"ISSN":["0893-3952"],"issn-type":[{"value":"0893-3952","type":"print"}],"subject":[],"published":{"date-parts":[[2021,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical, immunophenotypic and genomic findings of NK lymphoblastic leukemia: a study from the Bone Marrow Pathology Group","name":"articletitle","label":"Article Title"},{"value":"Modern Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1038\/s41379-021-00739-4","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 United States & Canadian Academy of Pathology.","name":"copyright","label":"Copyright"}]}}